These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30262122)

  • 21. Analysis of Driving Factors of Willingness to Use and Willingness to Pay for Existing Pharmacological Smoking Cessation Aids Among Young and Middle-Aged Adults in Germany.
    Aumann I; Treskova M; Hagemann N; von der Schulenburg JM
    Appl Health Econ Health Policy; 2016 Aug; 14(4):441-452. PubMed ID: 27021824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costs and benefits of smoking cessation aids: making a case for public reimbursement of nicotine replacement therapy in Australia.
    Bertram MY; Lim SS; Wallace AL; Vos T
    Tob Control; 2007 Aug; 16(4):255-60. PubMed ID: 17652241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Varenicline in the management of smoking cessation: a single technology appraisal.
    Hind D; Tappenden P; Peters J; Kenjegalieva K
    Health Technol Assess; 2009 Sep; 13 Suppl 2():9-13. PubMed ID: 19804684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation.
    Jackson KC; Nahoopii R; Said Q; Dirani R; Brixner D
    J Occup Environ Med; 2007 Apr; 49(4):453-60. PubMed ID: 17426529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation.
    Mahmoudi M; Coleman CI; Sobieraj DM
    Int J Clin Pract; 2012 Feb; 66(2):171-82. PubMed ID: 22257042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing Smoking Cessation in the United States: Expanding the Availability of Over-the-Counter Medications.
    Leischow SJ
    JAMA; 2019 Feb; 321(6):541-542. PubMed ID: 30653222
    [No Abstract]   [Full Text] [Related]  

  • 27. Crossing borders: factors affecting differences in cost-effectiveness of smoking cessation interventions between European countries.
    Vemer P; Rutten-van Mölken MP
    Value Health; 2010; 13(2):230-41. PubMed ID: 19804435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rethinking Priorities: Cost of Complications After Elective Colectomy.
    Zogg CK; Najjar P; Diaz AJ; Zogg DL; Tsai TC; Rose JA; Scott JW; Gani F; Alshaikh H; Canner JK; Schneider EB; Goldberg JE; Haider AH
    Ann Surg; 2016 Aug; 264(2):312-22. PubMed ID: 26501705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Smoking Cessation in Patients With Acute Coronary Syndrome.
    Franck C; Filion KB; Eisenberg MJ
    Am J Cardiol; 2018 May; 121(9):1105-1111. PubMed ID: 29526275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation.
    Nielsen K; Fiore MC
    Prev Med; 2000 Mar; 30(3):209-16. PubMed ID: 10684744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Cost-Effectiveness Analysis of Smoking-Cessation Interventions Prior to Posterolateral Lumbar Fusion.
    Zhuang T; Ku S; Shapiro LM; Hu SS; Cabell A; Kamal RN
    J Bone Joint Surg Am; 2020 Dec; 102(23):2032-2042. PubMed ID: 33038088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interventions for smoking cessation in 2018].
    Abdul-Kader J; Airagnes G; D'almeida S; Limosin F; Le Faou AL
    Rev Pneumol Clin; 2018 Jun; 74(3):160-169. PubMed ID: 29650283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Budgetary impact analysis on funding smoking-cessation drugs in patients with COPD in Spain.
    Jiménez-Ruiz CA; Solano-Reina S; Signes-Costa J; de Higes-Martinez E; Granda-Orive JI; Lorza-Blasco JJ; Riesco-Miranda JA; Altet-Gomez N; Barrueco M; Oyagüez I; Rejas J;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2027-36. PubMed ID: 26451100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoking cessation services in the Eastern Mediterranean Region: highlights and findings from the WHO Report on the Global Tobacco Epidemic 2019.
    AlMulla A; Hassan-Yassoub N; Fu D; El-Awa F; Alebshehy R; Ismail M; Fraser CP
    East Mediterr Health J; 2020 Jan; 26(1):110-115. PubMed ID: 32043553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
    Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
    Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness analysis of the first-line therapies for nicotine dependence.
    Cornuz J; Pinget C; Gilbert A; Paccaud F
    Eur J Clin Pharmacol; 2003 Jul; 59(3):201-6. PubMed ID: 12759795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cost-Effectiveness of Pharmacological Smoking Cessation Therapies - A Systematic Literature Review].
    Aumann I; Rozanski K; Damm K; Graf von der Schulenburg JM
    Gesundheitswesen; 2016 Oct; 78(10):660-671. PubMed ID: 27784123
    [No Abstract]   [Full Text] [Related]  

  • 39. Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment.
    Bozinoff N; Le Foll B
    Expert Rev Respir Med; 2018 Sep; 12(9):793-804. PubMed ID: 30092681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial.
    Benowitz NL; Pipe A; West R; Hays JT; Tonstad S; McRae T; Lawrence D; St Aubin L; Anthenelli RM
    JAMA Intern Med; 2018 May; 178(5):622-631. PubMed ID: 29630702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.